Prolotherapy Research - The Deterioration of Articular Cartilage in Osteoarthritis by Corticosteroid Injections

Previous Page

 

Conclusions

The Hackett-Hemwall technique of dextrose Prolotherapy used on patients who presented with over five years of unresolved hip pain were shown in this retrospective pilot study to improve their quality of life even 19 months subsequent from their last Prolotherapy session. The 61 patients with 94 hips treated reported significantly less pain, stiffness, crunching sensation, disability, depressed and anxious thoughts, medication and other pain therapy usage, as well as improved walking ability, range of motion, sleep, exercise ability, and activities of daily living. This included patients who were told there were no other treatment options for their pain or that surgery was their only option. The results confirm that Prolotherapy is a treatment that should be highly considered for people suffering with chronic hip pain. Future studies will be needed to confirm this pilot study and to document if Prolotherapy can keep chronic hip pain sufferers from needing hip surgeries including hip replacements.

Acknowledgements

Doug Puller (D.P.), independent data collector.
Dave Gruen (D.G.) independent data analyst from
www.bolderimage.com

Bibliography

  1. Kurtz S. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005 Jul;87(7):1487-97.
  2. Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum. 2008 Apr 15;59(4):481-8.
  3. Lee K, et al. Current state and future of joint replacements in the hip and knee. Expert Rev Med Devices. 2008 May;5(3):383-93.
  4. Agency for Healthcare Research and Quality (AHRQ). Agency News and Notes: Musculoskeletal procedures account for over 10 percent of all hospital care in the United States. Available at: www.ahrq.gov/research/aug07/0807RA32.htm. Accessed October 13, 2008.
  5. Freedman KB. A meta-analysis of thromboembolic prophylaxis for elective total hip arthroplasty. Paper presented at: Ninth Annual Meeting of the American Association of Hip and Knee Surgeons; November 12-14,1999; Dallas, Texas.
  6. Elfick A. Variation in the wear rate during the life of a total hip arthroplasty: A simulator and retrieval study. J Arthroplasty. 2000;379:34-40.
  7. Alternative treatments: Dealing with chronic pain. Mayo Clinic Health Letter. April 2005. 23(4).
  8. Lennard T. Pain Procedures in Clinical Practice. 2nd ed. Philadelphia, PA: Hanley & Belfus, Inc.;2000.
  9. Lennard T. Physiatric Procedures in Clinical Practice. Philadelphia, PA: Hanley & Belfus, Inc.;1995.
  10. Hackett G, et al. Ligament and Tendon Relaxation Treated by Prolotherapy. 5th ed. Oak Park, IL: Gustav A. Hemwall;1992.
  11. Reeves KD. Prolotherapy: Present and future applications in soft tissue pain and disability. Phys Med Rehabil Clin N Am. 1995;6:917- 926.
  12. Ongley M. Ligament instability of knees: a new approach to treatment. Manual Med. 1988;3:152-154.
  13. Hackett G. Prolotherapy in whiplash and low back pain. Postgrad Med. 1960;27:214-219.
  14. Kayfetz D. Occipital-cervical (whiplash) injuries treated by Prolotherapy. Med Trial Tech Quarterly. June 1963:9-29.
  15. Merriman J. Prolotherapy versus operative fusion in the treatment of joint instability of the spine and pelvis. J Inter Coll of Surg. 1964;42:150-159.
  16. Hackett G. Shearing injury to the sacroiliac joint. J Inter Coll Surg. 1954;22:631-639.
  17. Hackett G. Referred pain and sciatica in diagnosis of low back disability. J Am Med Assoc. 1957;163:183-185.
  18. Hackett G. Ligament and Tendon Relaxation Treated by Prolotherapy. Springfield, IL: Charles C. Thomas, 1958.
  19. Hackett G. Joint stabilization: An experimental, histologic study with comments on the clinical application in ligament proliferation. Am J Surg. 1955;89:968-973.
  20. Ongley M, et al. A new approach to the treatment of chronic low back pain. Lancet. July 1987:143-147.
  21. Echow E. A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain. Rheumatology. 1999;38(12):1255-9.
  22. Klein RG, et al. A randomized double-blind trial of dextroseglycerine- phenol injections for chronic low back pain. J Spinal Dis. 1993;6(1):23-33.
  23. Klein RG, et al. Proliferative injection for low back pain: Histologic changes of injected ligaments and objective measurements of lumbar spine mobility before and after treatment. J Neuro & Orthop Med & Surg. July 1989;10(2).
  24. Yelland MJ. Prolotherapy injections, saline injections and exercises for chronic low back pain: a randomized trial. Spine. 2004;29(1):9-16.
  25. Dagenais S. Intraligamentous injection of sclerosing solutions (Prolotherapy) for spinal pain: a critical review of literature. Spine J. 2005;5:310-328.
  26. Hackett G. Referral pain and sciatica in diagnosis of low back disability. J Am Med Assoc. 1957;163:183-185.
  27. Hackett G. Ligament and Tendon Relaxation Treated by Prolotherapy. 3rd ed. Springfield, IL: Charles C. Thomas, 1958.
  28. Schwarz R. Prolotherapy: A literature review and retrospective study. J Neuro, Orthop Med & Surg. 1991;12:220-229.
  29. Schmidt H. Effect of growth factors on proliferation of fibroblasts from the medial collateral and anterior cruciate ligaments. J Orthop Res. 1995;13:184-190.
  30. Liu Y. An in-situ study of the influence of a sclerosing solution in rabbit medial collateral ligaments and its junction strength. Connect Tissue Res. 1983;2:95-102.
  31. Maynard J. Morphological and biomechanical effects of sodium morrhuate on tendons. J Orthop Res. 1985;3:236-248.
  32. Hauser R, et al. Prolo Your Pain Away! 3rd ed. Beulah Land Press, Oak Park, IL. 2007.
  33. Cleveland Clinic total hip arthroplasty orthopedic surgery outcomes 2006, pp. 10-11.
  34. Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercises and manual therapy in the management of osteoarthritis. Phys Ther. 2005;85:907-71.
  35. Roddy E. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or kneethe MOVE consensus. Rheumatology. 2005;44:67-71.
  36. Garfinkel M. Yoga as a complementary therapy. Geriatr Aging. 2006;9:190-194.
  37. Pavelka K. Glucosamine sulfate prevents total joint replacement in the long-term follow-up of knee osteoarthritis patients. American College of Rheumatology 2004 meeting; October 16- 21, 2004; San Antonio, TX; presentation 251, poster board 252.
  38. Garellick G. Life expectancy and cost utility after total hip replacement. Clin Orthop Relat Res. 1998;346:141-151.
  39. Schmale G. Early failure of revision total hip arthroplasty with cemented precoated femoral components: comparison with uncemented components at 2 to 8 years. J Arthroplasty. 2000; Septmeber;15(6):718-729.
  40. Lieberman J. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. J Bone Joint Surg Am. 1997;79:319-325.
  41. Dorr L, et al. Causes of and treatment protocol for instability of total hip replacement. Clin Orthop Relat Res. 1998;355:144-151.
  42. American Association of Hip and Knee Surgeons. Minimally invasive & small incision joint replacement surgery: what patients should consider. Available at: www.aahks.org//web/pdf/MIS_ patients.pdf. Accessed December 11, 2008.
  43. Reeves K. Prolotherapy: Basic science, clinical studies and technique. In: Lennard TA, ed. Pain Procedures in Clinical Practice. 2nd ed. Philadelphia, PA: Hanley and Belfus; 2000:172-190.
  44. Alderman, D. Prolotherapy for knee pain. Pract Pain Manage. July/Aug 2007, pp. 70-79.
  45. Reeves KD, et al. Randomized prospective double-blind placebocontrolled study of dextrose Prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther. March 2000;6(2):68-80.
  46. Hauser R, et al. Standard clinical X-ray studies document cartilage regeneration in five degenerated knees after Prolotherapy. Journal of Prolotherapy. 2009;1:22-27.
  47. Alderman D. Prolotherapy for knee pain. Pract Pain Manage. July/ August 2007, pp.70-79.
  48. Bennett LD, et al. Meniscal and articular cartilage changes in knee osteoarthritis: a cross sectional double-contrast macrographic study. Rheumatology. 2002;41:917-923.
  49. Brandt KD. Transection of the anterior cruciate ligament in the dog: a model of osteoarthritis. Semin Arthritis Rheum. 1991;21(3 Suppl 2):22-32.
  50. Fleming BC, et al. Ligament injury, reconstruction and osteoarthritis. Curr Opin Orthop. 2005 Oct;16(5):354-362.
  51. HCUPnet, Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.ahrq.gov/data/hcup/hcupnet.htm. (accessed 2/08/2008)
  52. HCUP Databases (Nationwide Inpatient Sample). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, 1999-2003. Available at: www.hcupnet. ahrq.gov/HCUP. Accessed December 11, 2008.
  53. Illinois Hospital Price Survey Report: 2000. Provided by Illinois Health Care Cost Containment Council. Available at: www.state. il.us/agency/hcccc/freepub/survey00.pdf. Accessed December 11, 2008.
  54. Charges for Prolotherapy at Caring Medical and Rehabilitation Services, Oak Park, IL for 2007.
  55. Lane N. Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Arthritis Rheum. May 2004;50(5):1477-1486.

Previous Page

 
Recomended Reading

Journal of Prolotherapy